Page 35 - Haematologica - Vol. 105 n. 6 - June 2020

Geriatric assessment in older patients with a hematologic malignancy
Finke J. Geriatric assessment and quality of life in older patients considered for allogene- ic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis article. Bone Marrow Transplant. 2018;53(5):565-575.
51. Derman BA, Kordas K, Ridgeway J, et al. Results from a multidisciplinary clinic guid- ed by geriatric assessment before stem cell transplantation in older adults. Blood Adv. 2019;3(22):3488-3498.
52. Dubruille S, Libert Y, Roos M, et al. Identification of clinical parameters predic- tive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: major impact of cognition. J Geriatr Oncol. 2015;6(5):362- 369.
53. DuMontier C, Liu MA, Murillo A, et al. Function, survival, and care utilization among older adults with hematologic malig- nancies. J Am Geriatr Soc. 2019;(67):889- 897.
54. Hamaker ME, Augschoell J, Stauder R. Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hemato- logical malignancy. Leuk Lymphoma. 2016;57(11):2560-2567.
55. Huang LW, Sheng Y, Andreadis C, et al. Functional status as measured by geriatric assessment predicts inferior survival in older allogeneic hematopoietic cell transplanta- tion recipients: functional status predicts post-alloHCT survival. Biol Blood Marrow Transplant. 2020;(26):189-196.
56. Lin RJ, Elko TA, Devlin SM, et al. Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malig- nancies. Bone Marrow Transplant. 2020;(55):157-164.
57. Liu MA, DuMontier C, Murillo A, et al. Gait speed, grip strength, and clinical outcomes in older patients with hematologic malig- nancies. Blood. 2019;134(4):374-382.
58. Muffly LS, Kocherginsky M, Stock W, et al. Geriatric assessment to predict survival in older allogeneic hematopoietic cell trans- plantation recipients. Haematologica. 2014;99(8):1373-1379.
59. Nawas MT, Andreadis C, Martin TG, et al. Limitation in patient-reported function Is associated with inferior survival in older adults undergoing autologous hematopoiet- ic cell transplantation. Biol Blood Marrow Transplant. 2019;25(6):1218-1224.
60. Rodrigues M, de Souza PMR, de Oliveira Muniz Koch L, Hamerschlak N. The use of comprehensive geriatric assessment in older patients before allologeneic hematopoietic stem cell transplantation: a cross-sectional study. J Geriatr Oncol. 2020;(11):100-106.
61. Rollot-Trad F, Lahjibi H, Lazarovici C, Bauer C, Saint-Jean O, Gisselbrecht M. Haematological malignancies in older adults: experience in a geriatric acute care
department. Rev Med Interne. 2008;29(7):
541-549.
62. Silay K, Akinci S, Silay YS, et al.
Hospitalization risk according to geriatric assessment and laboratory parameters in elderly hematologic cancer patients. Asian Pacific J Cancer Prev. 2015;16(2):1783-1786.
63. Velghe A, Petrovic M, De Buyser S, Demuynck R, Noens L. Validation of the G8 screening tool in older patients with aggres- sive haematological malignancies. Eur J Oncol Nurs. 2014;18(6):645-648.
64. Klepin HD, Geiger AM, Tooze JA, et al. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc. 2011;59(10): 1837-1846.
65. Klepin HD, Tooze JA, Pardee TS, et al. Effect of intensive chemotherapy on physical, cog- nitive, and emotional health of older adults with acute myeloid leukemia. J Am Geriatr Soc. 2016;64(10):1988-1995.
66. Isaacs A, Fiala M, Tuchman S, Wildes TM. A comparison of three different approaches to defining frailty in older patients with multi- ple myeloma. J Geriatr Oncol. 2020;11(2):311-315.
67. Hamaker ME, Mitrovic M, Stauder R. The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy. Ann Hematol. 2014;93(6):1031-1040.
68. Hofer F, Koinig KA, Nagl L, Borjan B, Stauder R. Fatigue at baseline is associated with geri- atric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy. Ann Hematol. 2018;97(11):2235-2243.
69. Lin RJ, Shahrokni A, Dahi PB, et al. Pretransplant comprehensive geriatric assessment in hematopoietic cell transplan- tation: a single center experience. Bone Marrow Transplant. 2018;53:1184-1187.
70. Lin RJ, Dahi PB, Shahrokni A, et al. Feasibility of a patient-reported, electronic geriatric assessment tool in hematopoietic cell transplantation–a single institution pilot study. Leuk Lymphoma. 2019;60(13):3308- 3311.
71. Hshieh TT, Jung WF, Grande LJ, et al. Prevalence of cognitive impairment and association with survival among older patients with hematologic cancers. JAMA Oncol. 2018;4(5):686-693.
72. Muffly LS, Boulukos M, Swanson K, et al. Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnera- bilities in older transplant recipients. Biol Blood Marrow Transplant. 2013;19(3):429- 434.
73. Corre R, Greillier L, Le Caër H, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP
08-02 study. J Clin Oncol. 2016;34(13):1476-
1483.
74. Kirkhus L, Benth JŠ, Rostoft S, et al. Geriatric
assessment is superior to oncologists’ clini- cal judgement in identifying frailty. Br J Cancer. 2017;117(4):470-477.
75. Hamaker ME, te Molder M, Thielen N, van Munster BC, Schiphorst AH, van Huis LH. The effect of a geriatric evaluation on treat- ment decisions and outcome for older can- cer patients – a systematic review. J Geriatr Oncol. 2018;9(5):430-440.
76. Van Leeuwen KM, Van Loon MS, Van Nes FA, et al. What does quality of life mean to older adults? A thematic synthesis. PLoS One. 2019;14(3):1-39.
77. Stauder R, Lambert J, Desruol-Allardin S, et al. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: literature review and landscape analysis. Eur J Haematol. 2020 Jan 27. [Epub ahead of print]
78. Meneses-Echávez JF, González-Jiménez E, Ramírez-Vélez R. Supervised exercise reduces cancer-related fatigue: a systematic review. J Physiother. 2015;61(1):3-9.
79. Buffart LM, Kalter J, Sweegers MG, et al. Effects and moderators of exercise on quali- ty of life and physical function in patients with cancer: an individual patient data meta- analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91-104.
80. Baldwin C, Spiro A, Ahern R, Emery PW. Oral nutritional interventions in malnour- ished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(5):371-385.
81. Schuetz P, Fehr R, Baechli V, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019;393(10188):2312- 2321.
82. Caillet P, Liuu E, Raynaud Simon A, et al. Association between cachexia, chemothera- py and outcomes in older cancer patients: a systematic review. Clin Nutr. 2017;36:1473- 1482.
83. Kalsi T, Babic-Illman G, Ross PJ, et al. The impact of comprehensive geriatric assess- ment interventions on tolerance to chemotherapy in older people. Br J Cancer. 2015;112(9):1435-1444.
84. Bruns ERJ, van den Heuvel B, Buskens CJ, et al. The effects of physical prehabilitation in elderly patients undergoing colorectal sur- gery: a systematic review. Color Dis. 2016;18(8):267-277.
85. Driessen EJ, Peeters ME, Bongers BC, et al. Effects of prehabilitation and rehabilitation including a home-based component on physical fitness, adherence, treatment toler- ance, and recovery in patients with non- small cell lung cancer: a systematic review. Crit Rev Oncol Hematol. 2017;114:63-76.
86. ClinicalTrials.gov. U.S. National Library of Medicine [Internet]. [cited 2020 Feb 5]. Available from: https://clinicaltrials.gov/
haematologica | 2020; 105(6)
1493